OGSIVEO

This brand name is authorized in United States.

Active ingredients

The drug OGSIVEO contains one active pharmaceutical ingredient (API):

`1`	Nirogacestat UNII `QZ62892OFJ` - NIROGACESTAT
	Nirogacestat is a gamma secretase inhibitor that blocks proteolytic activation of the Notch receptor. When dysregulated, Notch can activate pathways that contribute to tumor growth.
	Read more about Nirogacestat

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OGSIVEO Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	82448-050

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.